Article thumbnail

Hypoxia Inhibits Osteogenesis in Human Mesenchymal Stem Cells through Direct Regulation of RUNX2 by TWIST

By Der-Chih Yang, Muh-Hwa Yang, Chih-Chien Tsai, Tung-Fu Huang, Yau-Hung Chen and Shih-Chieh Hung
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3170288
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
  2. (2004). A twist code determines the onset of osteoblast differentiation.
  3. (1995). Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice.
  4. (2008). Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.
  5. (2005). Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities.
  6. (2001). Analysis of type-I and type-II RUNX2 protein expression in osteoblasts.
  7. (2003). Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease.
  8. (1997). Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.
  9. (2005). Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression.
  10. (2008). Direct regulation of TWIST by HIF-1alpha promotes metastasis.
  11. (2004). Distinct osteogenic mechanisms of bones of distinct origins.
  12. (2002). Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality.
  13. (1998). Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor.
  14. (2007). Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
  15. (2011). Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through downregulation of E2A-p21 by HIF-TWIST.
  16. (2006). Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts.
  17. (1998). Hypoxia-inducible factor 1: master regulator of O2 homeostasis.
  18. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues.
  19. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.
  20. (2008). Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia.
  21. (2007). p53 downstream target DDA3 is a novel microtubule-associated protein that interacts with end-binding protein EB3 and activates beta-catenin pathway.
  22. (2007). Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan.
  23. (1988). Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein.
  24. (2005). Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics.
  25. (2003). Sclater A
  26. (2007). Shortterm exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo.
  27. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.
  28. (2005). TAZ, a transcriptional modulator of mesenchymal stem cell differentiation.
  29. (2007). The effect of hypoxia in development.
  30. (2007). The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.
  31. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development.
  32. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.
  33. (2009). TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment.
  34. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.